SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study

Intravenous recombinant tissue plasminogen activator (rtPA) is, besides mechanical thrombectomy, the highest class evidence based reperfusion treatment of acute ischemic stroke (AIS). The biggest concern of the therapy is symptomatic intracranial hemorrhage (sICH), which occurs in 3–7% of all treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaszewski, Bartosz, Gójska-Grymajło, Anna, Czaplewska, Paulina, Jabłoński, Bartosz, Lewandowska, Aleksandra E., Ossowska, Daria, Wyszomirski, Adam, Hałas, Marek, Szurowska, Edyta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455557/
https://www.ncbi.nlm.nih.gov/pubmed/34548538
http://dx.doi.org/10.1038/s41598-021-97710-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455557/
https://www.ncbi.nlm.nih.gov/pubmed/34548538
http://dx.doi.org/10.1038/s41598-021-97710-9

Ejemplares similares